Immunology of multiple sclerosis
Abstract
Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neurological deficits in multiple sclerosis patients result from two pathogenic events: acute inflammatory demyelination and axonal injury.
“Neurological deficits in MS patients result from two pathogenic events: acute inflammatory demyelination and axonal injury [150,151].”
From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [150]
Cites
Control of Regulatory T Cell Development by the Transcription Factor <i>Foxp3</i>
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · see citing works
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · see citing works
Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,327 · see citing works
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952 · see citing works
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918 · see citing works
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858 · see citing works
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848 · see citing works
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669 · see citing works
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667 · see citing works
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,648 · see citing works
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,545 · see citing works
A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller, D. H., Khan, O., Sheremata, W., Blumhardt, L., Rice, G., Libonati, M., Willmer-Hulme, A., Dalton, C., Miszkiel, K., & O'Connor, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,265 · see citing works
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., MALISSEN, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,170 · see citing works
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,098 · see citing works
The T lymphocyte in experimental allergic encephalomyelitis.
Zamvil, S., & Steinman, L. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003051 · Cited by 1,091 · see citing works
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,060 · see citing works
Immunological Aspects of Demyelinating Diseases
Martinꝉ, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,016 · see citing works
Self-citationSørensen, T. L., Tani, M., Jensen, J. S., Pierce, V., Lucchinetti, C. F., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F. T., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 993 · see citing works
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951 · see citing works
Epitope spreading in immune-mediated diseases: implications for immunotherapy
Vanderlugt, C. L., & Miller, S. D. (2002) · Nature reviews. Immunology · doi:10.1038/nri724 · Cited by 947 · see citing works
Fujinami, R. S., & Oldstone, M. B. A. (1985) · Science · doi:10.1126/science.2414848 · Cited by 947 · see citing works
T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis
Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., & Hafler, D. A. (1990) · Nature · doi:10.1038/346183a0 · Cited by 912 · see citing works
Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., AL-Sabbagh, A., dos Santos, L. M. B., Sayegh, M. H., Nussenblatt, R. B., De, T., & Hafler, D. A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004113 · Cited by 903 · see citing works
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891 · see citing works
Miyamoto, K., Miyake, S., & Yamamura, T. (2001) · Nature · doi:10.1038/35097097 · Cited by 879 · see citing works
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 855 · see citing works
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 850 · see citing works
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829 · see citing works
Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 828 · see citing works
Bielekova, B., Goodwin, B. L., Richert, N. D., Cortese, I. C. M., Kondo, T., Afshar, G., Gran, B., Eaton, J. K., Antel, J. P., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823 · see citing works
Self-citationMicroglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 782 · see citing works
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 759 · see citing works
Treatment of multiple sclerosis with gamma interferon
PANITCH, H. S., Hirsch, R. L., Schindler, J. D., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 752 · see citing works
Oldstone, M. B. A., Nerenberg, M. I., Southern, P. J., Price, J. A., & Lewicki, H. A. (1991) · Cell · doi:10.1016/0092-8674(91)90165-u · Cited by 751 · see citing works
THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE
Chabas, D., Baranzini, S. E., Mitchell, D. J., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M. V., Pedotti, R., et al. (2002) · International Conference on Osteopontin and SIBLING Proteins · doi:10.1100/tsw.2002.326 · Cited by 729 · see citing works
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed Central · Cited by 711 · see citing works
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 710 · see citing works
Goverman, J. M., Woods, A., Larson, L., Weiner, L. P., Hood, L., & Zaller, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90074-z · Cited by 684 · see citing works
Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T., Lee, J., & Sarvennick, N. (1998) · Nature Medicine · doi:10.1038/nm0798-781 · Cited by 670 · see citing works
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 660 · see citing works
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643 · see citing works
Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., & Reindl, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022328 · Cited by 617 · see citing works
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
Challoner, P. B., Smith, K., Parker, J. D. J., MacLeod, D. L., Coulter, S. N., Rose, T., Schultz, E. R., Bennett, J. L., Garber, R. L., & Chang, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7440 · Cited by 617 · see citing works
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 609 · see citing works
A genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & RISCH, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 608 · see citing works
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 595 · see citing works
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
Lang, H., Jacobsen, H. J., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L. S., Hjorth, P., Søndergaard, L., Svejgaard, A., Wucherpfennig, K. W., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 592 · see citing works
Pettinelli, C. B., & McFarlin, D. E. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1420 · Cited by 589 · see citing works
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S. L., Möurk, S., Choi, S. J., Kong, P. A., Hanley, D. F., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567 · see citing works
Storch, M., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 566 · see citing works
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., & Kim, B. S. (1997) · Nature Medicine · doi:10.1038/nm1097-1133 · Cited by 565 · see citing works
Genetics of multiple sclerosis
Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563 · see citing works
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 561 · see citing works
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B., Dwyer, B. K., & Shevach, E. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 534 · see citing works
Lafaille, J. J., Nagashima, K., Katsuki, M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90419-7 · Cited by 532 · see citing works
The epidemiology of multiple sclerosis
Goodin, D. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 517 · see citing works
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511 · see citing works
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 489 · see citing works
John, G. R., Shankar, S. L., Shafit‐Zagardo, B., Massimi, A. B., Lee, S. C., Raine, C. S., & Brosnan, C. F. (2002) · Nature Medicine · doi:10.1038/nm781 · Cited by 478 · see citing works
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T. R., Key, L., Durkalski, V., Tyor, W. R., Corboy, J. R., Markovic‐Plese, S., Preiningerova, J. L., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 471 · see citing works
Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., & Hafler, D. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1985 · Cited by 454 · see citing works
Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444 · see citing works
T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis
Allegretta, M., Nicklas, J. A., Sriram, S., & Albertini, R. J. (1990) · Science · doi:10.1126/science.1689076 · Cited by 436 · see citing works
Treatment of multiple sclerosis with the pregnancy hormone estriol
Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R. (2002) · Annals of Neurology · doi:10.1002/ana.10301 · Cited by 435 · see citing works
Flügel, A., Berkowicz, T., Ritter, T., Labeur, M. S., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., & Wekerle, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00143-1 · Cited by 431 · see citing works
Lafaille, J. J., de Keere, F. V., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426 · see citing works
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S. J., Haltia, M., Iivanainen, M. V., Morgan, P. B., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422 · see citing works
McFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071905 · Cited by 419 · see citing works
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406 · see citing works
The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis
van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., Ouagmiri, M. E., Polman, C. H., Lassmann, H., & Ravid, R. (1995) · Nature · doi:10.1038/375798a0 · Cited by 402 · see citing works
Klein, L., Klugmann, M., Nave, K., Tuohy, V. K., & Kyewski, B. (2000) · Nature Medicine · doi:10.1038/71540 · Cited by 392 · see citing works
Oksenberg, J. R., Stuart, S. J., Begovich, A. B., et al. (1990) · Nature · doi:10.1038/345344a0 · Cited by 391 · see citing works
Wraith, D. C., Smilek, D. E., Mitchell, D. J., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90287-0 · Cited by 390 · see citing works
Shared Human T Cell Receptor V β Usage to Immunodominant Regions of Myelin Basic Protein
Wucherpfennig, K. W., Ota, K., Endo, N., et al. (1990) · Science · doi:10.1126/science.1693015 · Cited by 386 · see citing works
Olsson, T. P., Zhi, W. W., Höjeberg, B., Kostulas, V., Jiang, Y., Anderson, G., Ekre, H. P., & Link, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114800 · Cited by 370 · see citing works
Schluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 370 · see citing works
Zhang, X. (2004) · International Immunology · doi:10.1093/intimm/dxh029 · Cited by 365 · see citing works
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364 · see citing works
Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis
Runmarker, B., & Andersen, O. (1995) · Brain · doi:10.1093/brain/118.1.253 · Cited by 356 · see citing works
Skulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., & Goebels, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308689100 · Cited by 348 · see citing works
Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W. H., & Berger, T. (1999) · Brain · doi:10.1093/brain/122.11.2047 · Cited by 347 · see citing works
Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J., Long, E. O., McFarlin, D. E., & McFarland, H. F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.2.540 · Cited by 342 · see citing works
Self-citationHafler, D. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21357 · Cited by 336 · see citing works
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor
Madsen, L. S., Andersson, E. C., Jansson, L., Krogsgaard, M., Andersen, C. B., Engberg, J., Strominger, J. L., Svejgaard, A., Hjorth, J. P., Holmdahl, R., et al. (1999) · Nature Genetics · doi:10.1038/15525 · Cited by 335 · see citing works
Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals
Pette, M., Fujita, K., Kitze, B., Whitaker, J. N., Albert, E., Kappos, L., & Wekerle, H. (1990) · Neurology · doi:10.1212/wnl.40.11.1770 · Cited by 333 · see citing works
Wucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., & Hafler, D. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.279 · Cited by 322 · see citing works
Qin, Y., Duquette, P., Zhang, Y., Talbot, P. J., Poole, R., & Antel, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 320 · see citing works
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320 · see citing works
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
Sun, J., Link, H., Olsson, T. P., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315 · see citing works
Bielekova, B., Richert, N. D., Howard, T., Blevins, G., Markovic‐Plese, S., McCartin, J., Wuerfel, J. T., Ohayon, J. M., Waldmann, T. A., McFarland, H. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402653101 · Cited by 314 · see citing works
Self-citationAntibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M. H., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314 · see citing works
Hemmer, B., Fleckenstein, B. T., Vergelli, M., Jung, G., McFarland, H. F., Martinꝉ, R., & Wiesmüller, K.-H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1651 · Cited by 313 · see citing works
Self-citationPette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J. T., Kappos, L., & Wekerle, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.7968 · Cited by 307 · see citing works
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
Wandinger, K.-P., Jabs, W. J., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H. J., Wessel, K., Kirchner, H., & Hennig, H. (2000) · Neurology · doi:10.1212/wnl.55.2.178 · Cited by 302 · see citing works
Development of biomarkers in multiple sclerosis
Bielekova, B., & Martinꝉ, R. (2004) · Brain · doi:10.1093/brain/awh176 · Cited by 299 · see citing works
Self-citationFogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J. A., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295 · see citing works
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294 · see citing works
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293 · see citing works
Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., & Linington, C. (1994) · Annals of Neurology · doi:10.1002/ana.410360714 · Cited by 291 · see citing works
Martinꝉ, R., Howell, M. D., Jaraquemada, D., et al. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.1.19 · Cited by 288 · see citing works
Self-citationHaines, J. L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 284 · see citing works
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
Pender, M. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.005 · Cited by 284 · see citing works
Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A., & Linington, C. (2001) · Glia · doi:10.1002/glia.1111 · Cited by 280 · see citing works
Ziemssen, T. (2002) · Brain · doi:10.1093/brain/awf252 · Cited by 268 · see citing works
van der Vliet, H. J., Blomberg, B. M. E. V., Nishi, N., Reijm, M., Voskuyl, A. E., Bodegraven, A. A. V., Polman, C. H., Rustemeyer, T., Lips, P. T. A. M., van den Eertwegh, A. J. M., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5060 · Cited by 267 · see citing works
Wood, D. D., Moscarello, M. A., Bilbao, J. M., & O'Connors, P. (1996) · Annals of Neurology · doi:10.1002/ana.410400106 · Cited by 266 · see citing works
Isolation of myelin basic protein-reactive T-cell lines from normal human blood
Burns, J. B., Rosenzweig, A., Zweiman, B., & Lisak, R. P. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90250-2 · Cited by 266 · see citing works
Ben‐Nun, A., & Cohen, I. R. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.1.303 · Cited by 261 · see citing works
Lovett‐Racke, A. E., Trotter, J. L., Lauber, J., Perrin, P. J., June, C. H., & Racke, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1528 · Cited by 260 · see citing works
Illés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T., & Yamamura, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4375 · Cited by 258 · see citing works
Sun, J., Olsson, T. P., Wang, W., Xiao, B., Kostulas, V., Fredrikson, S., Ekre, H.-P. T., & Link, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210620 · Cited by 257 · see citing works
Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., & Iglesias, A. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.169 · Cited by 257 · see citing works
Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses
Achiron, A., Gabbay, U., Gilad, R., et al. (1998) · Neurology · doi:10.1212/wnl.50.2.398 · Cited by 257 · see citing works
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253 · see citing works
Brocke, S., Gaur, A., Piercy, C., Gautam, A. M., Gijbels, K., Fathman, C. G., & Steinman, L. (1993) · Nature · doi:10.1038/365642a0 · Cited by 252 · see citing works
B cells and antibodies in CNS demyelinating disease
Cross, A. H., Trotter, J. L., & Lyons, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00409-4 · Cited by 252 · see citing works
Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., Šťastný, P., Douek, D. C., Koup, R. A., Racke, M. K., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4025 · Cited by 250 · see citing works
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
Scolding, N. J., Morgan, B. P., Houston, W. A. J., Linington, C., Campbell, A. K., & Compston, D. A. S. (1989) · Nature · doi:10.1038/339620a0 · Cited by 245 · see citing works
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12516 · Cited by 243 · see citing works
Self-citationTrebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242 · see citing works
Bielekova, B., Sung, M., Kadom, N., Simon, R. M., McFarland, H. F., & Martinꝉ, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3893 · Cited by 241 · see citing works
Self-citationCross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis
Tejada-Simon, M. V., Zang, Y. C. Q., Hong, J., Rivera, V. M., & Zhang, J. Z. (2003) · Annals of Neurology · doi:10.1002/ana.10425 · Cited by 238 · see citing works
Kotzin, B. L., Karuturi, S., Chou, Y. K., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9161 · Cited by 238 · see citing works
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
Robinson, W. H., da Fontoura, P. P., Lee, B. J., de Vegvar, H. E. N., Tom, J. A., Pedotti, R., DiGennaro, C., Mitchell, D. J., Fong, D., Ho, P. P.-K., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt859 · Cited by 236 · see citing works
Self-citationGraumann, U., Reynolds, R., Steck, A. J., & Schaeren‐Wiemers, N. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00485.x · Cited by 233 · see citing works
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
Karnezis, T., Mandemakers, W. J., McQualter, J. L., Zheng, B., Ho, P. P.-K., Jordan, K. A., Murray, B., Barres, B. A., Tessier‐Lavigne, M., & Bernard, C. C. A. (2004) · Nature Neuroscience · doi:10.1038/nn1261 · Cited by 230 · see citing works
Nash, R. A., Bowen, J. D., McSweeney, P. A., Pavletic, S. Z., Maravilla, K. R., Park, M.-S., Storek, J., Sullivan, K. M., Al-Omaishi, J., Corboy, J. R., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3908 · Cited by 221 · see citing works
Khademi, M., Illés, Z., Gielen, A. W., Marta, M., Takazawa, N., Baecher‐Allan, C., Brundin, L., Hannerz, J., Martin, C., Harris, R. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7169 · Cited by 215 · see citing works
Simpson, J. E., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D. K., & Woodroofe, M. N. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00274-5 · Cited by 214 · see citing works
Bomprezzi, R., Ringnér, M., Kim, S., Bittner, M. L., Khan, J. I., Chen, Y., ELKAHLOUN, A. G., Yu, A. Y., Bielekova, B., Meltzer, P. S., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg221 · Cited by 214 · see citing works
Self-citationCytokine-regulated proteases in autoimmune diseases
Opdenakker, G., & Damme, J. V. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90151-1 · Cited by 213 · see citing works
Burt, R. K., Cohen, B. A., Russell, E. J., Spero, K., Joshi, A., Oyama, Y., Karpus, W. J., Luo, K., Jovanovic, B. D., Traynor, A. E., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0877 · Cited by 210 · see citing works
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112516 · Cited by 210 · see citing works
Demyeliating neuropathy and monoclonal IgM antibody to myelin‐associated glycoprotein
Steck, A. J., Murray, N., Meier, C., et al. (1983) · Neurology · doi:10.1212/wnl.33.1.19 · Cited by 208 · see citing works
Immunoglobulins promote remyelination in the central nervous system
Rodriguez, M., & Lennon, V. A. (1990) · Annals of Neurology · doi:10.1002/ana.410270104 · Cited by 208 · see citing works
Wandinger, K., Lünemann, J. D., Wengert, O., Bellmann–Strobl, J., Aktaş, O., Weber, A., Grundström, E., Ehrlich, S., Wernecke, K. ‐., Volk, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13641-0 · Cited by 208 · see citing works
Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D., & Adorini, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116242 · Cited by 201 · see citing works
Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
Hilliard, B. A., Wilmen, A., Seidel, C., Liu, T.-S. T., Göke, R., & Chen, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1314 · Cited by 198 · see citing works
Mead, R. J., Singhrao, S. K., Neal, J., Lassmann, H., & Morgan, B. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.458 · Cited by 198 · see citing works
Waldner, H., Collins, M. A., & Kuchroo, V. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19388 · Cited by 198 · see citing works
Multiple sclerosis (second of two parts).
Mcfarlin, D., & McFarland, H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072005 · Cited by 198 · see citing works
Schluesener, H. J., & Wekerle, H. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3128 · Cited by 197 · see citing works
Krogsgaard, M., Wucherpfennig, K. W., Cannella, B., Hansen, B. E., Svejgaard, A., Pyrdol, J. W., Ditzel, H. J., Raine, C. S., Engberg, J., & Fugger, L. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1395 · Cited by 195 · see citing works
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
Scholz, C. W., Patton, K. T., Anderson, D. E., Freeman, G. J., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1532 · Cited by 194 · see citing works
Ben‐Nun, A., Liblau, R., Cohen, L., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2466 · Cited by 193 · see citing works
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes
Mitrovic, B., Ignarro, L. J., Vinters, H. V., Akers, M.-A., Schmid, I., Uíttenbogaart, C. H., & Merrill, J. E. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00491-m · Cited by 193 · see citing works
Wucherpfennig, K. W., Catz, I., Hausmann, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119622 · Cited by 192 · see citing works
Kojima, K., Berger, T., Lassmann, H., Hinze‐Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., & Linington, C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.817 · Cited by 188 · see citing works
Kabat, E. A., Freedman, D. A., Murray, J. P., et al. (1950) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195001000-00009 · Cited by 186 · see citing works
Berger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., & Lassmann, H. (1997) · PubMed · Cited by 185 · see citing works
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
Gibson, G. E., Haroutunian, V. H., Zhang, H., Park, L. C. H., Shi, Q., LESSER, M. L., Mohs, R. C., Sheu, R., & Blass, J. P. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 184 · see citing works
Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M. T., Pedemonte, E., Noonan, D. M., Albini, A., Bernardi, G., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202598 · Cited by 180 · see citing works
Vitamin D: a natural inhibitor of multiple sclerosis
Hayes, C. E. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000768 · Cited by 180 · see citing works
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt, A. B., Kropshofer, H., Kalbacher, H., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1665 · Cited by 178 · see citing works
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
Owens, G. P., Kannus, H., Burgoon, M. P., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430214 · Cited by 176 · see citing works
Wandinger, K., Stürzebecher, C.-S., Bielekova, B., Detore, G. R., Rosenwald, A., Staudt, L. M., McFarland, H. F., & Martinꝉ, R. (2001) · Annals of Neurology · doi:10.1002/ana.1096 · Cited by 176 · see citing works
Self-citationTreatment of multiple sclerosis with T–cell receptor peptides: Results of a double–blind pilot trial
Vandenbark, A. A., Chou, Y. K., Whitham, R. H., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1109 · Cited by 174 · see citing works
Immunomodulatory action of intravenous immunoglobulin
Sewell, W. A. C., & Jolles, S. R. A. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01545.x · Cited by 174 · see citing works
IMMUNOGLOBULIN-CONTAINING CELLS IN MULTIPLE-SCLEROSIS PLAQUES
Esiri, M. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91603-8 · Cited by 173 · see citing works
Walsh, M. J., & Tourtellotte, W. W. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.1.41 · Cited by 171 · see citing works
de Rosbo, N. K., Hoffman, M. A., Mendel, I., Yust, I., Kaye, J., Bakimer, R., Flechter, S., Abramsky, O., Milo, R., Karni, A., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271144 · Cited by 169 · see citing works
Stürzebecher, S., Wandinger, K., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P. A., Frank, J. A., Staudt, L. M., Martinꝉ, R., & McFarland, H. F. (2003) · Brain · doi:10.1093/brain/awg147 · Cited by 168 · see citing works
Self-citationAutologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
Mancardi, G., Saccardi, R., Filippi, M., Gualandi, F., Murialdo, A., Inglese, M., Marrosu, M. G., Meucci, G., Massacesi, L., Lugaresi, A., et al. (2001) · Neurology · doi:10.1212/wnl.57.1.62 · Cited by 168 · see citing works
Correale, J. D., Gilmore, W., McMillan, M., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2959 · Cited by 167 · see citing works
van der Laan, L. J. W., Ruuls, S. R., Weber, K. S., Lodder, I. J., Döpp, E. A., & Dijkstra, C. D. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00110-5 · Cited by 166 · see citing works
Subpopulations of human peripheral T gamma delta lymphocytes
Triebel, F., & Hercend, T. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90321-6 · Cited by 166 · see citing works
Evavold, B. D., Sloan‐Lancaster, J., Hsu, B. L., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3131 · Cited by 166 · see citing works
Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
Benczur, M., Petrányl, G. G., Pálffy, G., Varga, M., Tálas, M., Kotsy, B., Földeş, I., & Hollán, S. R. (1980) · PubMed Central · Cited by 165 · see citing works
Jurewicz, A., Biddison, W. E., & Antel, J. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.3056 · Cited by 165 · see citing works
Genetic models for CNS inflammation
Owens, T., Wekerle, H., & Antel, J. P. (2001) · Nature Medicine · doi:10.1038/84603 · Cited by 164 · see citing works
Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis
Link, J., Söderström, M. B., Olsson, T. P., Höjeberg, B., Ljungdahl, Å., & Link, H. (1994) · Annals of Neurology · doi:10.1002/ana.410360309 · Cited by 162 · see citing works
Issazadeh‐Navikas, S., Mustafa, M., Ljungdahl, Å., Höjeberg, B., Dagerlind, Å., Elde, R., & Olsson, T. P. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400503 · Cited by 158 · see citing works
Baranzini, S. E., Elfstrom, C., Chang, S.-Y. P., Butunoi, C., Murray, R. S., Higuchi, R., & Oksenberg, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6576 · Cited by 157 · see citing works
Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida, T., Parker, K. C., Turner, R. V., McFarland, H. F., Coligan, J. E., & Biddison, W. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10859 · Cited by 156 · see citing works
Waldner, H., Whitters, M. J., Sobel, R. A., Collins, M. A., & Kuchroo, V. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3412 · Cited by 156 · see citing works
Lindert, R.-B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H., & Hohlfeld, R. (1999) · Brain · doi:10.1093/brain/122.11.2089 · Cited by 154 · see citing works
Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity
Achiron, A., Gurevich, M., Friedman, N., Kaminski, N., & Mandel, M. (2004) · Annals of Neurology · doi:10.1002/ana.20008 · Cited by 153 · see citing works
Whitney, L. W., Ludwin, S. K., McFarland, H. F., & Biddison, W. E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00438-6 · Cited by 152 · see citing works
Hemmer, B., Vergelli, M., Gran, B., et al. (1998) · PubMed · Cited by 151 · see citing works
Tajouri, L., Mellick, A., Ashton, K., Tannenberg, A., Nagra, R., Tourtellotte, W., & Griffiths, L. (2003) · Brain Research. Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.008 · Cited by 147 · see citing works
The virology of demyelinating diseases
Johnson, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410360715 · Cited by 147 · see citing works
Saoudi, A., Simmonds, S. J., Huitinga, I., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.335 · Cited by 147 · see citing works
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
Zang, Y. C. Q., Li, S., Rivera, V. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5120 · Cited by 146 · see citing works
Mattson, D. H., Roos, R. P., & Arnason, B. G. W. (1980) · Nature · doi:10.1038/287335a0 · Cited by 146 · see citing works
Meinl, E., Weber, F., Drexler, K., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116879 · Cited by 146 · see citing works
Kivisäkk, P., Trebst, C., Liu, Z., Tucky, B. H., Sørensen, T. L., Rudick, R. A., Mack, M., & Ransohoff, R. M. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01947.x · Cited by 142 · see citing works
Kennedy, M., Tan, L., Canto, M. C. D., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.3.909 · Cited by 141 · see citing works
Ichikawa, H. T., Williams, L. P., & Segal, B. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2781 · Cited by 141 · see citing works
Sadatipour, B. T., Greer, J. M., & Pender, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440621 · Cited by 139 · see citing works
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.
Bánki, K., Colombo, E., SIa, F., Halladay, D. L., Mattson, D. H., Tatum, A. H., Massa, P. T., Phillips, P. E., & Perl, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1649 · Cited by 138 · see citing works
Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
Sriram, S., Mitchell, W. M., & Stratton, C. W. (1998) · Neurology · doi:10.1212/wnl.50.2.571 · Cited by 133 · see citing works
Richards, D. F., Fernandez, M., Caulfield, J., & Hawrylowicz, C. M. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8 · Cited by 133 · see citing works
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis
Utz, U., Biddison, W. E., McFarland, H. F., McFarlin, D. E., Flerlage, M., & Martinꝉ, R. (1993) · Nature · doi:10.1038/364243a0 · Cited by 130 · see citing works
Self-citationThe pathology of primary progressive multiple sclerosis
Brück, W., Lucchinetti, C., & Lassmann, H. (2002) · Multiple Sclerosis · doi:10.1191/1352458502ms785rr · Cited by 129 · see citing works
Sørensen, T. L., Sellebjerg, F. T., Jensen, C. V., Strieter, R. M., & Ransohoff, R. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00327.x · Cited by 128 · see citing works
Misu, T., Onodera, H., Fujihara, K., et al. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00456-2 · Cited by 127 · see citing works
CD1-restricted T-cell responses and microbial infection
Park, S.-H., & Bendelac, A. S. (2000) · Nature · doi:10.1038/35021233 · Cited by 124 · see citing works
Rajan, A. J., Gao, Y., Raine, C. S., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.941 · Cited by 123 · see citing works
Hemmer, B., Vergelli, M., Gran, B., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3631 · Cited by 123 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390 · see citing works
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950 · see citing works
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · see citing works
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523 · see citing works
Finucane, H. K., Reshef, Y. A., Anttila, V., Slowikowski, K., Gusev, A., Byrnes, A., Gazal, S., Loh, P.-R., Lareau, C., Shoresh, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0081-4 · Cited by 1,097 · see citing works
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · see citing works
Self-citationRevisiting the Mechanisms of CNS Immune Privilege
Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682 · see citing works
Molecular mimicry and autoimmunity
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627 · see citing works
Preferential recruitment of interferon‐γ–expressing T <sub>H</sub> 17 cells in multiple sclerosis
Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology · doi:10.1002/ana.21748 · Cited by 551 · see citing works
Sankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351 · see citing works
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353 · see citing works
Schwartz, M., & Baruch, K. (2014) · The EMBO Journal · doi:10.1002/embj.201386609 · Cited by 349 · see citing works
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Farez, M. F., Mascanfroni, I. D., Méndez-Huergo, S. P., Yeste, A., Murugaiyan, G., Garo, L. P., Balbuena Aguirre, M. E., Patel, B., Ysrraelit, M. C., Zhu, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.025 · Cited by 318 · see citing works
Jha, S., Srivastava, S. Y., Brickey, W. J., Iocca, H., Toews, A., Morrison, J. P., Chen, V. S., Gris, D., Matsushima, G. K., & Ting, J. P.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4088-10.2010 · Cited by 310 · see citing works
Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297 · see citing works
Lopes Pinheiro, M. A., Kooij, G., Mizee, M. R., Kamermans, A., Enzmann, G., Lyck, R., Schwaninger, M., Engelhardt, B., & de Vries, H. E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.018 · Cited by 247 · see citing works
Butyrate suppresses demyelination and enhances remyelination
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229 · see citing works
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., Chandrasekharan, U., DiCorleto, P. E., Trapp, B. D., Ransohoff, R. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3505 · Cited by 218 · see citing works
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200 · see citing works
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.-E., Nam, J. H., & Im, S.-H. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.001 · Cited by 212 · see citing works
Gaforio, J. J., Visioli, F., Alarcón-de-la-Lastra, C., Castañer, O., Delgado-Rodríguez, M., Fitó, M., Hernández, A. F., Huertas, J. R., Martínez-González, M. A., Menendez, J. A., et al. (2019) · Nutrients · doi:10.3390/nu11092039 · Cited by 187 · see citing works
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
Berglund, R., Guerreiro-Cacais, A. O., Adzemovic, M. Z., Zeitelhofer, M., Lund, H., Ewing, E., Ruhrmann, S., Nutma, E., Parsa, R., Thessen-Hedreul, M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5077 · Cited by 149 · see citing works
Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain · doi:10.1093/brain/aws212 · Cited by 145 · see citing works
The role of chemokines and chemokine receptors in multiple sclerosis
Cui, L.-Y., Chu, S.-F., & Chen, N.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106314 · Cited by 135 · see citing works
Choi, I. Y., Lee, C., & Longo, V. D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.042 · Cited by 133 · see citing works
CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ
Negi, N., & Das, B. K. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1357719 · Cited by 123 · see citing works
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111 · see citing works
Comabella, M., Craig, D. W., Camiña-Tato, M., Morcillo, C., Lopez, C., Navarro, A., Rio, J., BiomarkerMS Study Group, Montalban, X., & Martin, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003490 · Cited by 105 · see citing works
Self-citationContribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
Saikali, P., Antel, J. P., Pittet, C. L., Newcombe, J., & Arbour, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002188 · Cited by 101 · see citing works
Maki, T., Liang, A. C., Miyamoto, N., Lo, E. H., & Arai, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00275 · Cited by 99 · see citing works
Beneficial Effects of Spirulina Consumption on Brain Health
Trotta, T., Porro, C., Cianciulli, A., & Panaro, M. A. (2022) · Nutrients · doi:10.3390/nu14030676 · Cited by 98 · see citing works
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Noorbakhsh, F., Baker, G. B., & Power, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00134 · Cited by 95 · see citing works
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Mitsdoerffer, M., Kuchroo, V., & Korn, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12118 · Cited by 91 · see citing works
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination
Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., Veenstra, M., Ouyang, W., Ransohoff, R. M., & Li, X. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0841-12.2012 · Cited by 78 · see citing works
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells
Benedek, G., Zhang, J., Nguyen, H., Kent, G., Seifert, H. A., Davin, S., Stauffer, P., Vandenbark, A. A., Karstens, L., Asquith, M., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.007 · Cited by 64 · see citing works
Dziedzic, A., Miller, E., Saluk-Bijak, J., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051852 · Cited by 38 · see citing works
Pentón-Rol, G., Lagumersindez-Denis, N., Muzio, L., Bergami, A., Furlan, R., Fernández-Massó, J. R., Nazabal-Galvez, M., Llópiz-Arzuaga, A., Herrera-Rolo, T., Veliz-Rodriguez, T., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9642-9 · Cited by 36 · see citing works
Epstein-Barr Virus and Multiple Sclerosis
Lünemann, J. D., & Münz, C. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0038-y · Cited by 36 · see citing works
Miljković, Ž., Momčilović, M., Miljković, D., & Mostarica-Stojković, M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-37 · Cited by 35 · see citing works
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34 · see citing works
Hofer, L. S., Ramberger, M., Gredler, V., Pescoller, A. S., Rostásy, K., Sospedra, M., Hegen, H., Berger, T., Lutterotti, A., & Reindl, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01188 · Cited by 30 · see citing works
Self-citationDe Masi, R., Vergara, D., Pasca, S., Acierno, R., Greco, M., Spagnolo, L., Blasi, E., Sanapo, F., Trianni, G., & Maffia, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.002 · Cited by 26 · see citing works
Role for antibodies in altering behavior and movement
Libbey, J. E., & Fujinami, R. S. (2010) · Autism Research · doi:10.1002/aur.144 · Cited by 25 · see citing works
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Afzali, A. M., & Korn, T. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101947 · Cited by 25 · see citing works
Briggs, D. T., Martin, C. B., Ingersoll, S. A., Barnum, S. R., & Martin, B. K. (2007) · Glia · doi:10.1002/glia.20551 · Cited by 17 · see citing works
Mekhaeil, M., Conroy, M. J., & Dev, K. K. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01409-w · Cited by 8 · see citing works
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · see citing works
- Authors
- Sospedra, M., & Martin, R.
- Affiliations
- National Institutes of Health (US)
- Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
- ORCID
- Sospedra, Mireia
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2005-04-01
- Volume
- 23
- Issue
- 1
- Pages
- 683-747
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2113291839
- Cited by
- 2,149
- References
- 362
- Citations by year
- 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
- MeSH terms
- Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review